The authors identified lncRNA as the molecular mediator of CLL- sEVs effects; in fact, the same result was obtained by treating monocytes with the exogenous noncoding Y RNA hY4, found significantly enriched in both CLL-derived sEVs and sEVs from the plasma of CLL patients [152]. Here, RNY4 is linked to B-cell chronic lymphocytic leukemia.